Demand for lenacapavir, a long-acting HIV prevention injection given twice a year, has outstripped limited supplies in Uganda, Kenya and Malawi. Health officials and advocates from the three countries are warning against stirring up demand that health systems cannot meet. They spoke at a regional webinar on advancing…
observer.ug ↗



